Search

Your search keyword '"Grever, Michael R."' showing total 1,221 results

Search Constraints

Start Over You searched for: Author "Grever, Michael R." Remove constraint Author: "Grever, Michael R."
1,221 results on '"Grever, Michael R."'

Search Results

7. The long noncoding RNA, treRNA, decreases DNA damage and is associated with poor response to chemotherapy in chronic lymphocytic leukemia

8. Phase 2 study of ibrutinib in classic and variant hairy cell leukemia

12. Externally validated predictive clinical model for untreated del(17p13.1) chronic lymphocytic leukemia patients

13. Final results of EFC6663: A multicenter, international, phase 2 study of alvocidib for patients with fludarabine-refractory chronic lymphocytic leukemia

15. Near-tetraploidy is associated with Richter transformation in chronic lymphocytic leukemia patients receiving ibrutinib

16. Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia

22. Safety and activity of BTK inhibitor ibrutinib combined with ofatumumab in chronic lymphocytic leukemia: a phase 1b/2 study

32. Validation of ZAP-70 methylation and its relative significance in predicting outcome in chronic lymphocytic leukemia

34. FISH Analysis of CDKN2A/B Deletion in Chronic Lymphocytic Leukemia

35. Retrospective Analysis of Residual Hairy Cell Leukemia Measured By IHC or Flow Cytometry and Frontline Treatment with Pentostatin on Time to Next Treatment

36. Treatment of CLL-Associated Autoimmune Cytopenias and Outcomes in a Single Institution Cohort Study

37. Incidence, Description, and Timing of Serious or Opportunistic Infections in Patients with Hairy Cell Leukemia Treated with Purine Nucleoside Analogues

38. Characterizing the Development of Secondary Myelodysplastic Syndrome (MDS) with Antecedent or Concurrent Chronic Lymphocytic Leukemia (CLL) in the Era of Small Molecule Inhibitors for the Treatment of CLL

39. Extended Follow up of a Phase 2 Study of Ibrutinib in Hairy Cell Leukemia

40. Patient characteristics that predict Richter's transformation in patients with chronic lymphocytic leukemia treated with ibrutinib

43. Genome-wide methylation profiling in decitabine-treated patients with acute myeloid leukemia

45. Clinical and pharmacodynamic activity of bortezomib and decitabine in acute myeloid leukemia

46. Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine

47. Impact of sex on outcomes in patients with hairy cell leukemia (HCL): An HCL Patient Data Registry (PDR) analysis.

Catalog

Books, media, physical & digital resources